← Back to headlines
Medpace stock falls despite Q1 earnings beat
Medpace shares declined even after the company reported better-than-expected Q1 earnings, with its 2026 guidance ranges including consensus estimates.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Treasury Secretary Bessent's Bond Strategy Faces Scrutiny and Criticism
8h ago
Analysts Assess NVIDIA's Valuation and Volatility Risks Following Weekly Stock Decline
10h ago
Richtech Robotics Announces Stock Repurchase Program, Shares Rise
11h ago
Apollo, KKR, and IFM Investors Finalists in AB Ports Stake Sale
11h ago